Increased expression of macrophage migration inhibitory factor in the nucleus of the solitary tract attenuates renovascular hypertension in rats

American Journal of Hypertension

Volumn 30, Issue 4, 2017, Pages 435-443

  Barbosa, Rafaela Moreira ^a   Speretta, Guilherme F ^a   Martins Dias, Daniel Penteado ^b   Ruchaya, Prashant Jay ^a   Li, Hongwei ^c   Menani, José Vanderlei ^a   Sumners, Colin ^d   Colombari, Eduardo ^a   Colombari, Débora S A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

2K1C; Angiotensin II; AT1 receptor; Baroreflex; Blood pressure; Brainstem; Hypertension

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; ISOMERASE; MIF PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BRAIN STEM; COMPARATIVE STUDY; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; HEART RATE; HOLTZMAN RAT; IN VIVO GENE TRANSFER; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; SOLITARY TRACT NUCLEUS; TELEMETRY; URINE VOLUME; ANIMAL; DISEASE MODEL; DRINKING BEHAVIOR; EATING; GENE KNOCK-IN; GENETICS; KIDNEY ARTERY; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; SURGERY;

ANIMALS; ARTERIAL PRESSURE; BAROREFLEX; DISEASE MODELS, ANIMAL; DRINKING BEHAVIOR; EATING; GENE KNOCK-IN TECHNIQUES; HEART RATE; HYPERTENSION, RENOVASCULAR; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; SOLITARY NUCLEUS;

EID: 85021784878     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpx001     Document Type: Article

References (40)

1. Goldblatt H, Lynch J, Hanzal RF, Summerville W W. Studies on experimental hypertension: I. Te production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934; 59:347-379.
2. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002; 36:443-451.
3. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikof MS, Bergamaschi CT, Campos RR. Oxidative stress in the sympathetic pre-motor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 2009; 22:484-492.
4. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, Friberg P. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999; 99:2537-2542.
5. Morton JJ, Wallace EC. Te importance of the renin-angiotensin sys-tem in the development and maintenance of hypertension in the two-kidney one-clip hypertensive rat. Clin Sci (Lond) 1983; 64:359-370.
6. Oliveira-Sales EB, Toward MA, Campos RR, Paton JF. Revealing the role of the autonomic nervous system in the development and maintenance of Goldblatt hypertension in rats. Auton Neurosci 2014; 183:23-29.
7. Blanch GT, Freiria-Oliveira AH, Speretta GF, Carrera EJ, Li H, Speth RC, Colombari E, Sumners C, Colombari DS. Increased expression of angiotensin II type 2 receptors in the solitary-vagal complex blunts renovascular hypertension. Hypertension 2014; 64:777-783.
8. Berenguer LM, Garcia-Estañ J, Ubeda M, Ortiz AJ, Quesada T. Role of renin-angiotensin system in the impairment of barorefex control of heart rate in renal hypertension. J Hypertens 1991; 9:1127-1133.
9. Tsyrlin VA, Galagudza MM, Kuzmenko N V, Pliss MG, Rubanova NS, Shcherbin YI. Arterial baroreceptor refex counteracts long-term blood pressure increase in the rat model of renovascular hypertension. PLoS One 2013; 8:e64788.
10. Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Prolonged activation of the barorefex produces sustained hypotension. Hypertension 2004; 43:306-311.
11. Oliveira-Sales EB, Colombari DS, Davisson RL, Kasparov S, Hirata AE, Campos RR, Paton JF. Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 2010; 56:290-296.
12. Ciriello J, Hochstenbach SL, Roder S. Central projections of barorecep-tor and chemoreceptor aferents fbers in the rat. In Barraco IRA (ed), Nucleus of the Solitary Tract. CRC Press: Boca Raton, Florida, 1994, pp. 35-50.
13. Sato MA, Menani J V, Lopes OU, Colombari E. Lesions of the commis-sural nucleus of the solitary tract reduce arterial pressure in spontaneously hypertensive rats. Hypertension 2001; 38:560-564.
14. Freiria-Oliveira AH, Blanch GT, Li H, Colombari E, Colombari DS, Sumners C. Macrophage migration inhibitory factor in the nucleus of solitary tract decreases blood pressure in SHRs. Cardiovasc Res 2013; 97:153-160.
15. Bacher M, Meinhardt A, Lan HY, Dhabhar FS, Mu W, Metz CN, Chesney JA, Gemsa D, Donnelly T, Atkins RC, Bucala R. MIF expression in the rat brain: implications for neuronal function. Mol Med 1998; 4:217-230.
16. Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med 2002; 30:S27-S35.
17. Sun C, Li H, Leng L, Raizada MK, Bucala R, Sumners C. Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity. J Neurosci 2004; 24:9944-9952.
18. Busche S, Gallinat S, Fleegal MA, Raizada MK, Sumners C. Novel role of macrophage migration inhibitory factor in angiotensin II regulation of neuromodulation in rat brain. Endocrinology 2001; 142:4623-4630.
19. Matsumura K, Averill DB, Ferrario CM. Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the barorecep-tor refex. American Journal of Physiology 1998; 275:R1611-R1619.
20. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003; 139:191-202.
21. Li H, Gao Y, Qi Y, Katovich MJ, Jiang N, Braseth LN, Scheuer DA, Shi P, Sumners C. Macrophage migration inhibitory factor in hypothalamic paraventricular nucleus neurons decreases blood pressure in spontane-ously hypertensive rats. FASEB J 2008; 22:3175-3185.
22. Speretta GF, Silva AA, Vendramini RC, Zanesco A, Delbin MA, Menani J V, Bassi M, Colombari E, Colombari DS. Resistance training prevents the cardiovascular changes caused by high-fat diet. Life Sci 2016; 146:154-162.
23. Silva AS, Ariza D, Dias DP, Crestani CC, Martins-Pinge MC. Cardiovascular and autonomic alterations in rats with Parkinsonism induced by 6-OHDA and treated with L-DOPA. Life Sci 2015; 127:82-89.
24. Bertinieri G, Di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G. Evaluation of baroreceptor refex by blood pressure monitoring in unanesthetized cats. Am J Physiol 1988; 254:H377-H383.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408.
26. Tan PS, Killinger S, Horiuchi J, Dampney RA. Baroreceptor refex modulation by circulating angiotensin II is mediated by AT1 receptors in the nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 2007; 293:R2267-R2278.
27. Colombari E, Colombari DS, Li H, Shi P, Dong Y, Jiang N, Raizada MK, Sumners C, Murphy D, Paton JF. Macrophage migration inhibitory factor in the paraventricular nucleus plays a major role in the sympatho-excitatory response to salt. Hypertension 2010; 56:956-963.
28. Li H, Gao Y, Freire CD, Raizada MK, Toney GM, Sumners C. Macrophage migration inhibitory factor in the PVN attenuates the central pressor and dipsogenic actions of angiotensin II. FASEB J 2006; 20:1748-1750.
29. Petersson MJ, Rundqvist B, Johansson M, Eisenhofer G, Lambert G, Herlitz H, Jensen G, Friberg P. Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens 2002; 20:1181-1187.
30. Kirchheim HR. Systemic arterial baroreceptor refexes. Physiol Rev 1976; 56:100-177.
31. Nishi EE, Bergamaschi CT, Oliveira-Sales EB, Simon KA, Campos RR. Losartan reduces oxidative stress within the rostral ventrolateral medulla of rats with renovascular hypertension. Am J Hypertens 2013; 26:858-865.
32. Biancardi VC, Son SJ, Ahmadi S, Filosa JA, Stern JE. Circulating angi-otensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension 2014; 63:572-579.
33. Johnson AK, Loewy AD. Circumventricular organs and their role in visceral functions. In Loewy AD, Spyer KM (eds), Central Regulation of Autonomic Functions. Oxford University Press: New York, 1990, pp. 247-267.
34. Martins-Oliveira A, Castro MM, Oliveira DM, Rizzi E, Ceron CS, Guimaraes D, Reis RI, Costa-Neto CM, Casarini DE, Ribeiro AA, Gerlach RF, Tanus-Santos JE. Contrasting efects of aliskiren versus losartan on hypertensive vascular remodeling. Int J Cardiol 2013; 167:1199-1205.
35. Möhring J, Möhring B, Näumann H-J, Philippi A, Homsy E, Orth H, Dauda G, Kazda S. Salt and water balance and renin activity in renal hypertension of rats. Am J Physiol 1975; 228:1847-1855.
36. Burmeister MA, Young CN, Braga VA, Butler SD, Sharma RV, Davisson RL. In vivo bioluminescence imaging reveals redox-regulated activator protein-1 activation in paraventricular nucleus of mice with renovascu-lar hypertension. Hypertension 2011; 57:289-297.
37. Zimmerman MC, Davisson RL. Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol 2004; 84:125-149.
38. Cheng WH, Lu PJ, Ho WY, Tung CS, Cheng PW, Hsiao M, Tseng CJ. Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure. Circ Res 2010; 106:788-795.
39. Kudrin A, Ray D. Cunning factor: macrophage migration inhibitory factor as a redox-regulated target. Immunol Cell Biol 2008; 86:232-238.
40. La Rovere MT, Pinna GD, Maestri R, Sleight P. Clinical value of barore-fex sensitivity. Neth Heart J 2013; 21:61-63.